REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharma Ace Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Specialty (except Psychiatric and Substance Abuse) Hospitals
Full name: Pharma Ace Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Pharma Ace Sdn. Bhd. is based in Malaysia. The head office is in Petaling Jaya. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Pharma Ace Sdn. Bhd. was incorporated on January 16, 2008. In 2023, the company reported a net sales revenue increase of 47.4%. Its’ total assets recorded a growth of 20.76%. Pharma Ace Sdn. Bhd.’s net profit margin increased by 3.1% in 2023.

Headquarters
No. 22, Jalan Pju 3/46, Sunway Damansara
Petaling Jaya; Selangor; Postal Code: 47810

Contact Details: Purchase the Pharma Ace Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Pharma Ace Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Pharma Ace Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Pharma Ace Sdn. Bhd. report to view the information.
Incorporation Date:
January 16, 2008
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Pharma Ace Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
47.4%▲
Total operating revenue
47.4%▲
Operating profit (EBIT)
113.86%▲
EBITDA
109.89%▲
Net Profit (Loss) for the Period
110.26%▲
Total assets
20.76%▲
Total equity
161.29%▲
Operating Profit Margin (ROS)
4.25%▲
Net Profit Margin
3.1%▲
Return on Equity (ROE)
-14.98%▼
Quick Ratio
0.45%▲
Cash Ratio
-0.12%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo